home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops
Search  -  prev / next
 
 

Pharmaceutical and Biopharmaceutical Quality Control Laboratories - A Regulatory Compliance Primer

 
  January 23, 2018  
     
 
CfPIE - The Center for Professional Innovation & Education, Malvern, PA USA
October 22 & 23, 2018


Course Description - Course runs 9:00 to 5:00 both days (Breakfast & Lunch Included)

Upon completion of this course, you will:

  • Be conversant in the specialized language of laboratory compliance
  • Be very familiar with the cGMPs and other regulations as they impact QC labs
  • Know the current compliance "hot spots" that FDA and other regulatory authorities look for when inspecting QC labs
  • Understand how to effectively deal with laboratory deviations and OOS results
  • Have an understanding the what, how and why of laboratory equipment qualification and methods validation
  • Understand how to properly prepare your QC lab for audits and inspections

Who Should Attend

This two-day course is designed for all persons who work in, supervise, or are involved in the management of pharmaceutical, biopharmaceutical, and biologics Quality Control laboratories. The course will also be of benefit to entry-level Quality Assurance professionals and others who audit QC Labs, or whose responsibilities include insuring lab regulatory compliance. This course will also provide participants with an understanding of how to effectively handle out-of-specification results, deviations, laboratory investigations and Corrective and Preventive Actions.

 
 
Organized by: Center for Professional Innovation & Education
Invited Speakers:

Steven A. Ostrove, Ph.D.

Steven A. Ostrove, Ph.D.

Specialties: Regulatory, R&D

Steven A. Ostrove, Ph.D., has been involved in the Bio-Pharmaceutical business for over 35 years and is an invited course leader, lecturer and guest speaker for both national and international conferences.

In 1999, he opened Ostrove Associates, Inc. (OAI) – a validation, compliance and regulatory-affairs consulting company – to provide consulting services to both major pharmaceutical/biotechnology companies and small, start-up companies.

Previously, Dr. Ostrove worked as Senior Technical Specialist in the Technical Service Department of Pharmacia Biotechnology. He also served as Senior Director of Validation and Regulatory Affairs with a number of major design/build engineering companies.

In addition, Dr. Ostrove has also served as an adjunct professor of Pharmaceutical Engineering for Validation and Regulatory Affairs for the New Jersey Institute of Technology and as an adjunct professor of Biology for Kean College. He recently served as industry representative on an FDA advisory panel and as Acting Manager of Validation for a contract pharmaceutical/OTC manufacturer.

Other Courses:

Publications:

Dr. Ostrove wrote a book in June 2016 titled, “How to Validate a Pharmaceutical Process, 1st Edition.” He has also published several book chapters, reference pieces and feature articles in a number of noted industry publications.

How to Validate a Pharmaceutical Process

New FDA Guidance on Data Integrity, Classifying Co-Crystals

 
Deadline for Abstracts: N/A
 
Registration: https://www.cfpie.com/ProductDetails.aspx?ProductID=268
E-mail: info@cfpie.com
 
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2018 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.